Interferon-alpha induces transient suppressors of cytokine signalling expression in human T cells

Experimental and Clinical Immunogenetics

Volumn 18, Issue 2, 2001, Pages 80-85

  Brender, Christine ^a   Nielsen, Mette ^a   Röpke, Garsten ^a   Nissen, Mogens Holst ^a   Svejgaard, Arne ^b   Billestrup, Nils ^c   Geisler, Carsten ^a   Ødum, Niels ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c NOVO NORDISK A S   (Denmark)

Author keywords

Interferon ; Interleukin 2; Suppressors of cytokine signalling; T cells

Indexed keywords

ALPHA INTERFERON; CELL PROTEIN; CYTOKINE; INTERLEUKIN 2; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALLING 1; SUPPRESSOR OF CYTOKINE SIGNALLING 2; SUPPRESSOR OF CYTOKINE SIGNALLING 3; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; INCUBATION TIME; KINETICS; LYMPHOCYTE CULTURE; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

CARRIER PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-2; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEINS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0035002992     PISSN: 02549670     EISSN: None     Source Type: Journal    
DOI: 10.1159/000049186     Document Type: Article

References (21)

1. Heim MH: The Jak-STAT pathway: Cytokine signalling from the receptor to the nucleus. J Recept Signal Transduct Res 1999;19:75-120.
2. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ: A family of cytokine-inducible inhibitors of signalling. Nature 1997;387:917-921.
3. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A: A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997;387:921-924.
4. Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T: Structure and function of a new STAT-induced STAT inhibitor. Nature 1997;387:924-929.
5. Hilton DJ, Richardson RT, Alexander WS, Viney EM, Willson TA, Sprigg NS, Starr R, Nicholson SE, Metcalf D, Nicola NA: Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci USA 1998;95: 114-119.
6. Matsumoto A, Masuhara M, Mitsui K, Yokouchi M, Ohtsubo M, Misawa H, Miyajima A, Yoshimura A: CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 1997;89:3148-3154.
7. Auernhammer CJ, Bousquet C, Melmed S: Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc Natl Acad Sci USA 1999;96:6964-6969.
8. Dickensheets HL, Venkataraman C, Schindler U, Donnelly RP: Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression. Proc Natl Acad Sci USA 1999; 96:10800-10805.
9. Ito S, Ansari P, Sakatsume M, Dickensheets H, Vazquez N, Donnelly RP, Larner AC, Finbloom DS: Interleukin-10 inhibits expression of both interferon alpha-and interferon gamma-induced genes by suppressing tyrosine phosphorylation of STAT1. Blood 1999;93:1456-1463.
10. Begley CG, Nicola NA: Resolving conflicting signals: Cross inhibition of cytokine signaling pathways. Blood 1999;93:1443-1447.
11. Parronchi P, De Carli M, Manetti R, Simonelli C, Sampognaro S, Piccinni MP, Macchia D, Maggi E, Del Prete G, Romagnani S: IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J Immunol 1992;149:2977-2983.
12. Brinkmann V, Geiger T, Alkan S, Heusser CH: Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J Exp Med 1993;178:1655-1663.
13. Tough DF, Borrow P, Sprent J: Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996;272:1947-1950.
14. Wang Q, Miyakawa Y, Fox N, Kaushansky K: Interferon-alpha directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1. Blood 2000;96:2093-2099.
15. Crespo A, Filla MB, Russell SW, Murphy WJ: Indirect induction of suppressor of cytokine signalling-1 in macrophages stimulated with bacterial lipopolysaccharide: Partial role of autocrine/paracrine interferon-alpha/beta. Biochem J 2000;349: 99-104.
16. Sakamoto H, Yasukawa H, Masuhara M, Tanimura S, Sasaki A, Yuge K, Ohtsubo M, Ohtsuka A. Fujita T, Ohta T, Furukawa Y, Iwase S, Yamada H, Yoshimura A: A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons. Blood 1998;92:1668-1676.
17. Odum N, Hartzman R, Jakobsen BK, Morling N, Platz P, Robbins FM, Ryder LP, Svejgaard A: The HLA-DP polymorphism in Denmark investigated by local and international PLT reagents. Definition of two 'new' DP antigens. Tissue Antigens 1986;28:105-118.
18. Nielsen M, Odum N, Bendtzen K, Ryder LP, Jakobsen BK, Svejgaard A: MHC class II molecules regulate growth in human T cells. Exp Clin Immunogenet 1994;11:23-32.
19. Brender C, Nielsen M, Kaltoft K, Mikkelsen G, Zhang Q, Wasik MA, Billestrup N, Ødum N: STAT3 mediated constitutive expression of SOCS-3 in cutaneous T cell lymphoma. Blood 2001;97:1056-1062.
20. Cohney SJ, Sanden D, Cacalano NA, Yoshimura A, Mui A, Migone TS, Johnston JA: SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STATS phosphorylation and lymphocyte proliferation. Mol Cell Biol 1999;19: 4980-4988.
21. Nicholson SE, Willson TA, Farley A, Starr R, Zhang JG, Baca M, Alexander WS, Metcalf D, Hilton DJ, Nicola NA: Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J 1999;18:375-385.